• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Evolus

< Previous 1 2 3 4 Next >
News headline image
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 14, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Reports Third Quarter 2025 Financial Results
November 05, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus to Participate in 2025 Stifel Healthcare Conference
October 28, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus to Report Third Quarter Financial Results on November 5, 2025
October 22, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 12, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Announces the Appointment of Tatjana Mitchell as Chief Financial Officer
September 08, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Announces Positive Data From Pivotal Trial for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product at 2025 Cosmetic Bootcamp
August 25, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product
August 20, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 08, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Reports Second Quarter 2025 Financial Results and Provides Business Updates
August 05, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Announces Publication of Independent Study in JAMA Dermatology Demonstrating Jeuveau® as a Top Performer Among Leading Neurotoxins
July 31, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus to Report Second Quarter Financial Results on August 5, 2025
July 22, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 11, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Expands Global Footprint with Introduction of Nuceiva® (botulinum toxin type A) in France
July 09, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 13, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolysse™ Recognized in 2025 Shape Skin Awards
June 10, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Announces Departure of its Chief Financial Officer
May 27, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Announces Publication of U.S. Pivotal Study for Evolysse™ Form and Evolysse™ Smooth Injectable Hyaluronic Acid Gels
May 22, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 16, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Reports First Quarter 2025 Results
May 07, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Strengthens Balance Sheet with Refinancing; Reducing Cost of Capital and Expanding Financial Flexibility
May 05, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus to Report First Quarter Financial Results on May 7, 2025
April 23, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 18, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Announces Commercial Launch of Evolysse™
April 16, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Launches “Drop the F Word” Campaign in Advance of the Commercial Launch of Evolysse™ Injectable Hyaluronic Acid Gels
April 15, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference
March 25, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 21, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance
March 04, 2025
From Evolus
Via Business Wire
Tickers EOLS
News headline image
Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences
February 27, 2025
From Evolus
Via Business Wire
Tickers EOLS
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap